Telmisartan (Micardis) — Research Compounds Library | RetatrutideCompare

Angiotensin II receptor blocker with partial PPAR-γ agonism. FDA-approved for hypertension and reduction of cardiovascular risk in patients ≥55 with high CV risk who can't take ACE inhibitors.